Ambenonium
Description
Ambenonium (as ambenonium dichloride) is a cholinesterase inhibitor used in the management of myasthenia gravis. Ambenonium exerts its actions against myasthenia gravis by competitive reversible inhibition of acetylcholinesterase, the enzyme responsible for the hydrolysis of acetylcholine.
ATC Classification
2D Molecule Structure
Unique Ingredient Identifier (UNII)
L16PUN799N - AMBENONIUM
CAS Registry Number
115-79-7 - ambenonium chloride
SNOMED-CT
387197009 - Ambenonium (substance)